بدائل البحث:
significant treatment » significant investment (توسيع البحث), significant enrichment (توسيع البحث), significant impairment (توسيع البحث)
treatment decrease » treatment decreased (توسيع البحث), treatments decreased (توسيع البحث), treatment increases (توسيع البحث)
point decrease » point increase (توسيع البحث)
main decrease » gain decreased (توسيع البحث), mean decrease (توسيع البحث), small decrease (توسيع البحث)
significant treatment » significant investment (توسيع البحث), significant enrichment (توسيع البحث), significant impairment (توسيع البحث)
treatment decrease » treatment decreased (توسيع البحث), treatments decreased (توسيع البحث), treatment increases (توسيع البحث)
point decrease » point increase (توسيع البحث)
main decrease » gain decreased (توسيع البحث), mean decrease (توسيع البحث), small decrease (توسيع البحث)
-
1
-
2
Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index.
منشور في 2025"…All groups were compared by Kruskal Wallis test with <i>post hoc</i> test after Dunn with Bonferroni adjustment showing significant decreased Ki-67 labeling index of <i>Cina1</i> compared to <i>Cina2</i> (p = 0.006) and the untreated CKD groups (p = 0.0001 and p = 0.0002, respectively). …"
-
3
-
4
-
5
-
6
<i>Elsholtzia ciliata</i> extract (ECE) treatment decreases coronavirus-induced plaque formation.
منشور في 2025"…Cells were overlayed 0.3% agarose, incubated for 4 days, and stained with crystal violets. <b>(B)</b> ECE treatment decreases plaque formation in a dose-dependent manner. …"
-
7
Summary of post-treatment disease course measures from MDMA-AT publications.
منشور في 2025الموضوعات: -
8
-
9
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
منشور في 2025الموضوعات: -
10
Summary of post-treatment disease course measures from clinical trials with psychotherapies.
منشور في 2025الموضوعات: -
11
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
منشور في 2025الموضوعات: -
12
Summary of post-treatment disease course measures from off-label medications clinical trials.
منشور في 2025الموضوعات: -
13
Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.
منشور في 2025الموضوعات: -
14
-
15
-
16
Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.
منشور في 2025الموضوعات: -
17
-
18
-
19
-
20